Practice
Featured experience
GSK collaboration with Flagship Pioneering
We are advising GSK on the transaction
Azul $800 million secured notes offering
The senior secured notes are due 2028
Kenvue $4.37 billion IPO
The carve-out of the former Johnson & Johnson consumer health business is the largest U.S. IPO since November 2021
NBCUniversal partnership with MultiChoice to relaunch Showmax using Peacock
We are advising NBCUniversal on the transaction to relaunch MultiChoice’s Showmax service using the Peacock platform
Davis Polk Advises One Madison Corporation on Its Combination with Ranpak
Davis Polk is advising One Madison Corporation on its acquisition of Ranpak Corporation from affiliates of Rhône Capital…
Davis Polk Advises Nutrisystem on Its Acquisition by Tivity Health
Davis Polk is advising Nutrisystem, Inc. on its $1.4 billion acquisition by Tivity Health, Inc. The transaction, which is…
Davis Polk Advises Mereo BioPharma Group plc on Its Combination with OncoMed Pharmaceuticals, Inc.
Davis Polk is advising Mereo BioPharma Group plc on its combination with OncoMed Pharmaceuticals, Inc. The transaction,…
Taiwan Liposome Company, Ltd. Initial Public Offering
Davis Polk advised the book-running manager and representative of the underwriters in connection with the initial public…
Baker Hughes long-term agreements with General Electric to maximize value
Davis Polk is advising Baker Hughes, a GE company on a series of long-term agreements that amend the commercial and…
Davis Polk Advises Calm.com, Inc. on an Investment in XpresSpa Group, Inc. and Concurrent Collaboration Agreement
Davis Polk advised Calm.com, Inc. in connection with its investment in preferred stock of XpresSpa Group, Inc. Concurrent…
Davis Polk Advises Cornell Capital on Its Acquisition of Frédéric Fekkai Brands in Partnership with Frédéric Fekkai
Davis Polk advised Cornell Capital LLC, in partnership with Frédéric Fekkai, in connection with the acquisition of…
Heineken strategic partnership with China Resources to join forces in China
Davis Polk is advising Heineken N.V. in connection with its entry into definitive agreements with China Resources Enterprise…
Orchard Therapeutics plc Initial Public Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the…
Davis Polk Advises Novo Nordisk on Its Acquisition of U.S. and Canadian Rights to Macrilen from Strongbridge Biopharma
Davis Polk is advising Novo Nordisk on its $145 million acquisition of the U.S. and Canadian rights to Macrilen from…